Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
82%
Severe Acute Respiratory Syndrome Coronavirus 2
77%
COVID-19
53%
Hematopoietic Cell
33%
Epitope
30%
Hematopoietic Stem Cell Transplantation
30%
Cell Transplantation
28%
Cytomegalovirus Infection
24%
Cytomegalovirus
24%
T Cell
23%
Intravenous Immunoglobulin
21%
Cohort Effect
21%
Seroconversion
20%
Aspergillus fumigatus
20%
Aspergillosis
20%
Aspergillus
19%
HBsAg
19%
Citrobacter
19%
Antibiotic Sensitivity
19%
Antimicrobial Agent
19%
Hepatitis B Antigen
19%
Antigen
18%
Hepatitis B Surface Antibody
14%
Enzyme-Linked Immunosorbent Assay
13%
Real Time Polymerase Chain Reaction
12%
Virus Nucleocapsid
12%
Monospecific Antibody
12%
Interferon Gamma
12%
Immune Response
12%
Enterobacterales
11%
Adoptive Immunity
11%
Humoral Immunity
11%
Tandem Repeat
11%
Breakthrough Infection
9%
Bacterial Strain
9%
Immune Evasion
9%
Organisms
9%
Polymerase Chain Reaction
9%
Benzalkonium Chloride
9%
Lineages
9%
Polymerase Chain Reaction
9%
Zoster Vaccine
9%
DNA Extraction
9%
Antimicrobial Stewardship
9%
Comorbidity
9%
Lateral Flow Assay
9%
Cell Assay
9%
Immunoassay
9%
Molecular Phylogeny
9%
Drug Resistance
9%
Medicine and Dentistry
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
Infection
37%
Pneumonia
30%
Systemic Mycosis
29%
Bloodstream Infection
26%
Hematopoietic Stem Cell Transplantation
22%
B Cell
22%
Cohort Effect
21%
Immunocompromised Patient
20%
Retrospective Cohort Study
19%
Cohort Analysis
19%
Sulfhemoglobinemia
19%
Drug Megadose
19%
Antimicrobial Agent
17%
Patient
16%
Computer Assisted Tomography
14%
Sensitivity and Specificity
14%
Assay
14%
Guanine Nucleotide Binding Protein
14%
Corticosteroid
14%
Antibiotics
14%
Acute Myeloid Leukemia
12%
Hematologic Malignancy
12%
False Positive Result
12%
Polymerase Chain Reaction
12%
Seroconversion
11%
Galactomannan
11%
Antiinfective Agent
10%
Odds Ratio
9%
T Cell
9%
Hepatitis B Antigen
9%
Leukemia
9%
Antibiogram
9%
Didecyldimethylammonium Chloride
9%
Immunoglobulin G
9%
Blood Analysis
9%
Virus Transmission
9%
Acute Leukemia
9%
Rapid Test
9%
Epitope
9%
Copurification
9%
B-Cell Lymphoma
9%
Depletion
9%
Inpatient
9%
Therapeutic Procedure
9%
Cell Therapy
9%
Mucormycosis
9%
Aspergillosis
9%
Pneumocystis Jirovecii
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
58%
Cohort Study
49%
Bloodstream Infection
39%
Infection
36%
Systemic Mycosis
24%
Lung Aspergillosis
24%
Acute Myeloid Leukemia
21%
Leukemia
19%
Coronavirinae
19%
Pharmacokinetics
19%
Corticosteroid
16%
Aspergillus
16%
Antimicrobial Agent
16%
Antibiotics
13%
Tubulin
12%
Invasive Aspergillosis
11%
Aspergillus fumigatus
11%
Galactomannan
9%
Cytomegalovirus Infection
9%
Diseases
9%
Observational Study
9%
Infectious Complication
9%
Coronavirinae
9%
Hematologic Disease
9%
Organisms
9%
Infusion Fluid
9%
Bloodstream Infection
9%
Hematologic Disease
9%
Fluconazole
9%
Acute Leukemia
9%
Citrobacter
9%
Varicella Zoster Vaccine
9%
Amphotericin B Lipid Complex
9%
Carbapenem
9%
Immunocompromised Patient
9%
Chemotherapy Regimens
9%
Amphotericin B
9%
Pneumonia
9%
Pneumocystis Jiroveci
9%
Letermovir
9%
HIV
9%
Antifungal Agent
8%
Quaternary Ammonium Derivative
8%
Herpes Zoster
7%
Benzalkonium Chloride
6%
Pyrrole
6%
Neutropenia
6%
Normal Human
6%
Antibiotic Resistance
5%
Corticosteroid
5%